Facebook
Twitter
LinkedIn
ForwardUpdate on Substance Abuse and Addiction (Fall 2022 Home Study)
Care of the patient with substance use and/or addiction requires collaboration with members of the interprofessional health care team. The knowledge gained at this session will help clinicians better understand the etiology, presentation, and treatment of addiction, including the pharmacist's role in care.
Update on Substance Use and Addiction - Agenda
- Introductions
- Susan Skledar, RPh, MPH, FASHP, Director of Experiential Learning, and Professor, University of Pittsburgh School of Pharmacy
- Welcome from Dean Amy Seybert
- Overview of the Pathophysiology of Addiction and New Addictive Substances
- Maureen Reynolds, PhD, Research Associate Professor, Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy
- Epidemiology of Drugs of Misuse, the Stigma of Substance Use, and the Role of the Pharmacist
- Jan Pringle, Professor and Director, Program Evaluation and Research Unit (PERU), University of Pittsburgh School of Pharmacy
- Session wrap-up
- Susan Skledar, RPh, MPH, FASHP, Director of Experiential Learning, and Professor, University of Pittsburgh School of Pharmacy
Target Audience
This course is targeted to educate Nurses, Nurse Practitioners, Pharmacists, Physicians, Physician Assistants, and Social Workers.
Learning Objectives
Overview of the Pathophysiology of Addiction and New Addictive Substances Learning Objectives
1. Recognize and explain the 3 facets that comprise the etiology of addictive disorders
2. Identify at least 2 brain structures involved with the “Go” and “Stop” in addiction processes.
3. Identify at least 2 sources for current information on Novel Psychoactive Substances (NPS), and the classifications for the most prevalent NPS found in the past year.
Epidemiology of Drugs of Misuse, the Stigma of Substance Use, and the Role of the Pharmacist Learning Objectives
1. Describe treatment and practices associated with opioid use disorder
2. Identify the ways that patients are currently clinically presenting and recognize the stigma associated with substance use
3. Learn how the pharmacist plays a major role in this public health emergency
Susan Skledar, RPh, MPH, FASHP - Director of Experiential Learning, and Professor, University of Pittsburgh School of Pharmacy
Amy Seybert, PharmD - Dean, and Professor, University of Pittsburgh School of Pharmacy
Maureen Reynolds, PhD - Research Associate Professor, Department of Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy
Jan Pringle - Professor and Director, Program Evaluation and Research Unit (PERU), University of Pittsburgh School of Pharmacy
Conflict of Interest Disclosure
Dr. Seybert discloses being a consultant and having 2 advisory meetings with Pfizer. No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
Disclaimer Statement
The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (ACPE)
The maximum number of hours awarded for this Continuing Pharmacy Education activity is 2.0 contact hours.
JA4008223-0000-22-085-H08-P
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.
Available Credit
- 2.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
- 2.00 Attendance